114 related articles for article (PubMed ID: 10789590)
21. Improved in vivo delivery of m-THPC via pegylated liposomes for use in photodynamic therapy.
Bovis MJ; Woodhams JH; Loizidou M; Scheglmann D; Bown SG; Macrobert AJ
J Control Release; 2012 Jan; 157(2):196-205. PubMed ID: 21982898
[TBL] [Abstract][Full Text] [Related]
22. Uptake and kinetics of 14C-labelled meta-tetrahydroxyphenylchlorin and 5-aminolaevulinic acid in the C6 rat glioma model.
Obwegeser A; Jakober R; Kostron H
Br J Cancer; 1998 Sep; 78(6):733-8. PubMed ID: 9743291
[TBL] [Abstract][Full Text] [Related]
23. Photodynamic therapy effect of m-THPC (Foscan) in vivo: correlation with pharmacokinetics.
Jones HJ; Vernon DI; Brown SB
Br J Cancer; 2003 Jul; 89(2):398-404. PubMed ID: 12865935
[TBL] [Abstract][Full Text] [Related]
24. Tumor selectivity at short times following systemic administration of a liposomal temoporfin formulation in a murine tumor model.
Svensson J; Johansson A; Gräfe S; Gitter B; Trebst T; Bendsoe N; Andersson-Engels S; Svanberg K
Photochem Photobiol; 2007; 83(5):1211-9. PubMed ID: 17880517
[TBL] [Abstract][Full Text] [Related]
25. Intratumor injection as a more effective means of porphyrin administration for photodynamic therapy.
Amano T; Prout GR; Lin CW
J Urol; 1988 Feb; 139(2):392-5. PubMed ID: 3339759
[TBL] [Abstract][Full Text] [Related]
26. Time-dependent biodistribution of tetra(m-hydroxyphenyl)chlorin and benzoporphyrin derivative monoacid ring A in the hamster model: comparative fluorescence microscopy study.
Andrejevic Blant S; Ballini JP; van den Bergh H; Fontolliet C; Wagnières G; Monnier P
Photochem Photobiol; 2000 Mar; 71(3):333-40. PubMed ID: 10732452
[TBL] [Abstract][Full Text] [Related]
27. Distribution and excretion of radiolabeled temoporfin in a murine tumor model.
Whelpton R; Michael-Titus AT; Jamdar RP; Abdillahi K; Grahn MF
Photochem Photobiol; 1996 Jun; 63(6):885-91. PubMed ID: 8992509
[TBL] [Abstract][Full Text] [Related]
28. Distribution of temoporfin, a new photosensitizer for the photodynamic therapy of cancer, in a murine tumor model.
Whelpton R; Michael-Titus AT; Basra SS; Grahn M
Photochem Photobiol; 1995 Apr; 61(4):397-401. PubMed ID: 7740084
[TBL] [Abstract][Full Text] [Related]
29. Photodynamic therapy in fibrosarcoma BALB/c animal model: Observation of the rebound effect.
Eugenia EM; Ángel PM; Anabella G; Solange B; Carlos P; Horacio P; Mario G
Photodiagnosis Photodyn Ther; 2018 Mar; 21():98-107. PubMed ID: 29155337
[TBL] [Abstract][Full Text] [Related]
30. Localization of liposomal mTHPC formulations within normal epithelium, dysplastic tissue, and carcinoma of oral epithelium in the 4NQO-carcinogenesis rat model.
de Visscher SA; Witjes MJ; van der Vegt B; de Bruijn HS; van der Ploeg-van den Heuvel A; Amelink A; Sterenborg HJ; Roodenburg JL; Robinson DJ
Lasers Surg Med; 2013 Dec; 45(10):668-78. PubMed ID: 24174342
[TBL] [Abstract][Full Text] [Related]
31. Photodynamic effects in vitro in fresh gynecologic tumors analyzed with a bioluminescence method.
Schlosser V; Koechli OR; Cattaneo R; Jentsch B; Haller U; Walt H
Clin Chem Lab Med; 1999 Feb; 37(2):115-20. PubMed ID: 10219498
[TBL] [Abstract][Full Text] [Related]
32. Indirect detection of photosensitizer ex vivo.
Bourré L; Thibaut S; Briffaud A; Rousset N; Eléouet S; Lajat Y; Patrice T
J Photochem Photobiol B; 2002 May; 67(1):23-31. PubMed ID: 12007464
[TBL] [Abstract][Full Text] [Related]
33. Photothrombic activity of m-THPC-loaded liposomal formulations: pre-clinical assessment on chick chorioallantoic membrane model.
Pegaz B; Debefve E; Ballini JP; Wagnières G; Spaniol S; Albrecht V; Scheglmann DV; Nifantiev NE; van den Bergh H; Konan-Kouakou YN
Eur J Pharm Sci; 2006 May; 28(1-2):134-40. PubMed ID: 16504490
[TBL] [Abstract][Full Text] [Related]
34. Development of a topical hematoporphyrin derivative formulation: characterization of photosensitizing effects in vivo.
McCullough JL; Weinstein GD; Lemus LL; Rampone W; Jenkins JJ
J Invest Dermatol; 1983 Dec; 81(6):528-32. PubMed ID: 6227672
[TBL] [Abstract][Full Text] [Related]
35. Treatment of mouse carcinomas with intratumoral injections of hematoporphyrin derivative and red light.
Moseng D; Volden G; Midelfart K; Kavli G; Christensen T; Moan J
Photodermatol; 1985 Apr; 2(2):107-10. PubMed ID: 4034416
[TBL] [Abstract][Full Text] [Related]
36. [Pharmacokinetics of photosensitizer m-THPC in rat models of liver cancer via orthotropic implantation using Walker-256].
Wang JD; Quan ZW; Shen J; Zhou XP; Luo FH; Wang SY; Yan JH; Yang D
Zhonghua Wai Ke Za Zhi; 2011 Apr; 49(4):341-5. PubMed ID: 21612701
[TBL] [Abstract][Full Text] [Related]
37. Time-resolved fluorescence spectroscopy of a hematoporphyrin derivative used for photodynamic therapy of cancer.
Gottschlich S; Lippert BM; Schade W; Werner JA
Res Commun Mol Pathol Pharmacol; 1997 Nov; 98(2):237-40. PubMed ID: 9467832
[TBL] [Abstract][Full Text] [Related]
38. Comparison of photosensitizers in saline and liposomes for tumor photodynamic therapy and skin phototoxicity.
Davis RK; Straight R; Kereszti Z
Laryngoscope; 1990 Jul; 100(7):682-6. PubMed ID: 2362527
[TBL] [Abstract][Full Text] [Related]
39. Photodynamic therapy of murine skin tumors using Photofrin-II.
Mukhtar H; Agarwal R; Athar M; Lewen RL; Elmets CA; Bickers DR
Photodermatol Photoimmunol Photomed; 1991 Aug; 8(4):169-75. PubMed ID: 1839955
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms for optimising photodynamic therapy: second-generation photosensitisers in combination with mitomycin C.
van Geel IP; Oppelaar H; Oussoren YG; Schuitmaker JJ; Stewart FA
Br J Cancer; 1995 Aug; 72(2):344-50. PubMed ID: 7640216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
